The hospital chain currently has an ARPOB of around ₹38,250.
He expects the oncology business, currently operational in two facilities to expand to 14 more locations, gathering pace over the next 2-3 quarters.
The women and childcare services, offered as part of the hospital’s multispecialty offerings, are expected to outpace other specialities in the coming years.
Rao highlighted that KIMS initially focused on six core specialities: cardiac sciences, renal sciences, gastro sciences, orthopaedics, and neurosciences. Oncology was not part of the original offerings. Among these, renal sciences led with 80% of the contribution, followed by cardiac sciences at 20%, neurosciences at 10%, and gastro sciences at 5-6%.
As health conditions evolve with increasing diseases and ageing populations, the hospital group introduced oncology services.
Also Read: KIMS signs MoU with Wipro GE Healthcare worth up to ₹700 crore
KIMS is set to enhance its healthcare infrastructure as well by adding 1,800 beds over the next two years through a mix of greenfield and brownfield expansion projects.
Under its brownfield projects, KIMS will expand its Kondapur facility by 500 beds in a phased manner, with completion targeted by April-June 2026 (Q1FY27).
In Anantapur, 250 new beds are expected by January-March 2026 (Q4FY26).
The Srikakulam and Ongole facilities will add 120 and 50 beds, respectively, by January-March 2025 (Q4FY25).
The greenfield projects include two facilities in Bengaluru, with Project 1 adding 415 beds and Project 2 contributing 250 beds, both slated for completion by the fourth quarter this year.
In Thane, a 300-bed hospital is also expected to be operational by end of this financial year.
KIMS has entered into operational and management (O&M) agreements for two hospitals, each with 200 beds, set to commence operations in the ongoing quarter.
These include a hospital in Kannur and another in Guntur, further expanding the group’s footprint.
Also Read: Krishna Institute of Medical Sciences enters Kerala after deal with Sree Chand Hospital
The hospital chain’s consolidated revenue for the July-September quarter grew to ₹773 crore from ₹653 crore last year. Earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew to ₹214 crore from ₹178 crore, with EBITDA margin improving marginally to 27.67%. Profit after tax grew to ₹121 crore from ₹101 crore last year.
Krishna Institute of Medical Sciences has a market value of about ₹23,962.32 crore. Its shares have risen by nearly 57% over the past year.
For more details, watch the accompanying video
